Loading the section…
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 30/04/2026 | 31/01/2026 | 31/07/2025 | 30/04/2025 | 31/01/2025 | 31/07/2024 |
|---|---|---|---|---|---|---|
| Research and development | 1M | 1M | 1M | 1M | 2M | 2M |
| Selling, general and administrative | 1M | 2M | 1M | 2M | 2M | 2M |
| Operating expenses | 3M | 3M | 2M | 3M | 3M | 4M |
| Operating income | −3M | −3M | −2M | −3M | −3M | −4M |
| Net income | −3M | −3M | −2M | −3M | −3M | −3M |
| Earnings per share | −0.07 | −0.08 | −0.07 | −0.09 | −0.10 | −0.10 |
| Earnings per share, diluted | −0.07 | −0.08 | −0.07 | −0.09 | −0.10 | −0.10 |
| Weighted average shares | 34M | 33M | 32M | 32M | 32M | 32M |
| Weighted average shares, diluted | 34M | 33M | 32M | 32M | 32M | 32M |
| Metric | 30/04/2026 | 31/01/2026 | 31/10/2025 | 31/07/2025 | 30/04/2025 | 31/01/2025 | 31/10/2024 | 31/07/2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 1M | 2M | 1M | 1M | 2M | 1M | 1M | 1M |
| Short-term investments | 12M | 13M | 14M |
| Metric | 31/01/2026 | 31/01/2025 |
|---|---|---|
| Operating cash flow | −3M | −3M |
| Share-based compensation | 768,000 | 1M |
| Investing cash flow | 1M | 3M |
| Financing cash flow | 2M | −17,000 |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 15M |
| 14M |
| 16M |
| 19M |
| 20M |
| Receivables | 56,000 | — | — | — | — | — | 173,000 | 410,000 |
| Current assets | 15M | 15M | 16M | 17M | 17M | 19M | 21M | 23M |
| Total assets | 15M | 15M | 16M | 18M | 17M | 19M | 22M | 23M |
| Current liabilities | 2M | 1M | 2M | 2M | 2M | 2M | 3M | 2M |
| Total liabilities | 2M | 1M | 2M | 2M | 2M | 2M | 3M | 2M |
| Equity | 14M | 15M | 15M | 17M | 15M | 17M | 20M | 21M |
| Shares outstanding | 34M | 33M | 33M | 33M | 32M | 32M | 32M | 32M |
| Shares issued | 34M | 33M | 33M | 33M | 32M | 32M | 32M | 32M |
| Treasury shares | — | — | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | — |